174 related articles for article (PubMed ID: 20464485)
1. Predicting prostate biopsy outcome: artificial neural networks and polychotomous regression are equivalent models.
Lawrentschuk N; Lockwood G; Davies P; Evans A; Sweet J; Toi A; Fleshner NE
Int Urol Nephrol; 2011 Mar; 43(1):23-30. PubMed ID: 20464485
[TBL] [Abstract][Full Text] [Related]
2. Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy.
Park SJ; Miyake H; Hara I; Eto H
Int J Urol; 2003 Feb; 10(2):68-71. PubMed ID: 12588600
[TBL] [Abstract][Full Text] [Related]
3. [Improvement of transrectal ultrasound. Artificial neural network analysis (ANNA) in detection and staging of prostatic carcinoma].
Loch T; Leuschner I; Genberg C; Weichert-Jacobsen K; Küppers F; Retz M; Lehmann J; Yfantis E; Evans M; Tsarev V; Stöckle M
Urologe A; 2000 Jul; 39(4):341-7. PubMed ID: 10957776
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte-to-monocyte ratio is a predictor of clinically significant prostate cancer at prostate biopsy.
Cho MC; Yoo S; Choo MS; Son H; Jeong H
Prostate; 2021 Dec; 81(16):1278-1286. PubMed ID: 34516662
[TBL] [Abstract][Full Text] [Related]
5. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
7. Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL.
Lee DH; Nam JK; Park SW; Lee SS; Han JY; Lee SD; Lee JW; Chung MK
Yonsei Med J; 2016 May; 57(3):565-71. PubMed ID: 26996553
[TBL] [Abstract][Full Text] [Related]
8. Predicting the outcome of prostate biopsy in a racially diverse population: a prospective study.
Porter CR; O'Donnell C; Crawford ED; Gamito EJ; Sentizimary B; De Rosalia A; Tewari A
Urology; 2002 Nov; 60(5):831-5. PubMed ID: 12429310
[TBL] [Abstract][Full Text] [Related]
9. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy.
Kronz JD; Shaikh AA; Epstein JI
Hum Pathol; 2001 Apr; 32(4):389-95. PubMed ID: 11331955
[TBL] [Abstract][Full Text] [Related]
10. Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies.
Scattoni V; Roscigno M; Freschi M; Dehò F; Raber M; Briganti A; Fantini G; Nava L; Montorsi F; Rigatti P
Arch Ital Urol Androl; 2005 Mar; 77(1):31-6. PubMed ID: 15906787
[TBL] [Abstract][Full Text] [Related]
11. Stratification of prostate-specific antigen level and results of transrectal ultrasonography and digital rectal examination as predictors of positive prostate biopsy.
Clark TW; Goldenberg L; Cooperberg PL; Wong AD; Singer J
Can Assoc Radiol J; 1997 Aug; 48(4):252-8. PubMed ID: 9282157
[TBL] [Abstract][Full Text] [Related]
12. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Clinically Significant Prostate Cancer After a Diagnosis of Atypical Small Acinar Proliferation, High-grade Prostatic Intraepithelial Neoplasia, or Benign Tissue.
Wiener S; Haddock P; Cusano J; Staff I; McLaughlin T; Wagner J
Urology; 2017 Dec; 110():161-165. PubMed ID: 28888752
[TBL] [Abstract][Full Text] [Related]
14. Significance of atypical small acinar proliferation and extensive high-grade prostatic intraepithelial neoplasm in clinical practice.
Adamczyk P; Wolski Z; Butkiewicz R; Nussbeutel J; Drewa T
Cent European J Urol; 2014; 67(2):136-41. PubMed ID: 25140226
[TBL] [Abstract][Full Text] [Related]
15. Detection rate and factors predictive the presence of prostate cancer in patients undergoing ultrasonography-guided transperineal saturation biopsies of the prostate.
Novara G; Boscolo-Berto R; Lamon C; Fracalanza S; Gardiman M; Artibani W; Ficarra V
BJU Int; 2010 May; 105(9):1242-6. PubMed ID: 19863531
[TBL] [Abstract][Full Text] [Related]
16. An artificial neural network to predict the outcome of repeat prostate biopsies.
Remzi M; Anagnostou T; Ravery V; Zlotta A; Stephan C; Marberger M; Djavan B
Urology; 2003 Sep; 62(3):456-60. PubMed ID: 12946746
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between screening by stratifying cases into groups on prostate specific antigen level and the positive rate of transrectal ultrasound guided systematic sextant prostate biopsy].
Cao XL; Gao JP; Han G; Tang J; Hong BF
Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):372-5. PubMed ID: 16638344
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening.
Zackrisson B; Aus G; Lilja H; Lodding P; Pihl CG; Hugosson J
Eur Urol; 2003 Apr; 43(4):327-32. PubMed ID: 12667711
[TBL] [Abstract][Full Text] [Related]
19. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels.
Roehrborn CG; Pickens GJ; Sanders JS
Urology; 1996 Mar; 47(3):347-52. PubMed ID: 8633400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
